InsidersTradesSigma
Explore the complete record of transactions filed by Håkan Englund, Director. Insider active across 2 companies, notably Prostatype Genomics AB. In total, 1 disclosures have been published. The latest transaction was disclosed on 4 June 2025 — Purchase. Regulator: FIN-FSA. The full history is accessible without signup.
1 of 1 declaration
Håkan Englund is a board member of Prostatype Genomics AB. He plays a crucial role in the strategic direction of the company, participating in board meetings and contributing to important decision-making. Prostatype Genomics AB focuses on developing innovative solutions in the field of genomics, aiming to improve treatments for patients.